SeaStar Medical Holding Corporation (ICU)
Automate Your Wheel Strategy on ICU
With Tiblio's Option Bot, you can configure your own wheel strategy including ICU - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ICU
- Rev/Share 0.0497
- Book/Share 0.0656
- PB 9.2921
- Debt/Equity 0.6425
- CurrentRatio 0.9647
- ROIC -19.0956
- MktCap 9831940.0
- FreeCF/Share -1.7606
- PFCF -0.648
- PE -0.3301
- Debt/Assets 0.0478
- DivYield 0
- ROE 6.0184
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: July 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 5,242,464 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.763 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, …
Read More
SeaStar Medical Announces Positive Nasdaq Listing Determination
Published: July 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
DENVER, July 02, 2025 (GLOBE NEWSWIRE) -- Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it has received confirmation from The Nasdaq Stock Market that the Company has evidenced compliance with the minimum $2.5 million stockholders' equity requirement and all other applicable criteria for continued listing on The Nasdaq Capital Market. Accordingly, the previously disclosed listing matter has been closed.
Read More
SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
Published: June 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
Cincinnati Children's Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that the QUELIMMUNE therapy will be featured in a two-part video series that will be available on the SeaStar Medical website. The videos describe the adoption and the use of the QUELIMMUNE therapy for pediatric patients at the nationally recognized Cincinnati Children's Hospital Medical …
Read More
SeaStar Medical Announces Pricing of Up to $8 Million Public Offering
Published: June 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants $4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
Read More
SeaStar Medical to Report First Quarter Financial Results on May 14, 2025
Published: May 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
DENVER, May 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 14, 2025, and host a webcast and conference call to discuss its financial results and business progress.
Read More
SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
DENVER, April 30, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today that Eric Schlorff, CEO of SeaStar Medical, will be a featured guest today, Wednesday, April 30th, at approximately 10:50 am Eastern Time on the Benzinga All Access Show.
Read More
About SeaStar Medical Holding Corporation (ICU)
- IPO Date 2021-03-18
- Website https://www.seastarmedical.com
- Industry Biotechnology
- CEO Eric Schlorff
- Employees 19